PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799607
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799607
Global Patient Blood Management Market Size Study & Forecast, by Product (Instrument, Accessories, Reagents, Software) and End User (Blood Bank, Hospital) and Regional Forecasts 2025-2035
Global Patient Blood Management Market is valued approximately at USD 15.3 billion in 2024 and is anticipated to expand at a CAGR of 7.40% over the forecast period 2025-2035. Patient Blood Management (PBM) encompasses a multidisciplinary approach aimed at optimizing the care of patients who might require transfusion, integrating advanced diagnostic techniques, blood conservation strategies, and innovative technologies to ensure improved patient outcomes. The market growth is propelled by increasing prevalence of chronic diseases, rising surgical procedures, and heightened awareness regarding blood safety and management protocols. Additionally, the adoption of technologically advanced instruments and software solutions for monitoring, storage, and transfusion is catalyzing market expansion.
The accelerating demand for efficient blood management solutions is primarily driven by the surging number of surgical interventions, growing incidence of anemia, and the need to minimize transfusion-related complications. Instruments such as centrifuges, apheresis devices, transfusion devices, and advanced storage equipment are increasingly being deployed to enhance patient outcomes and operational efficiency. Moreover, healthcare institutions are integrating software solutions for blood inventory management and predictive analytics, enabling real-time monitoring and optimized utilization of blood products. The advent of next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies is further broadening market potential, offering precise diagnostics and tailored therapeutic interventions. Nevertheless, high costs associated with advanced PBM systems and stringent regulatory compliance may pose challenges to market growth.
Regionally, North America holds a commanding share of the Global Patient Blood Management Market, owing to the presence of advanced healthcare infrastructure, extensive adoption of cutting-edge medical technologies, and a robust network of hospitals and blood banks. Europe follows closely, driven by rising awareness programs, government initiatives promoting safe transfusion practices, and the prevalence of sophisticated diagnostic instruments. Asia Pacific is expected to witness the fastest growth throughout the forecast period, fueled by expanding healthcare infrastructure, increasing surgical volumes, and rising investments in medical technologies across China, India, Japan, and Australia. Latin America and the Middle East & Africa are anticipated to present lucrative opportunities due to growing healthcare expenditures and improving blood management practices.
Major market players included in this report are:
- Fresenius Kabi AG
- Terumo Corporation
- Haemonetics Corporation
- Grifols, S.A.
- Macopharma SA
- Bio-Rad Laboratories, Inc.
- Cerus Corporation
- Miltenyi Biotec
- Baxter International Inc.
- Becton, Dickinson and Company
- Danaher Corporation
- Siemens Healthineers
- Roche Diagnostics
- GE Healthcare
- Luminex Corporation
Global Patient Blood Management Market Report Scope:
- Historical Data - 2023, 2024
- Base Year for Estimation - 2024
- Forecast period - 2025-2035
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Product:
- Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device)
- Accessories (Syringes, Vials)
- Reagents
- Software
By End User:
- Blood Bank
- Hospital
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- RoE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- RoMEA
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2025 to 2035.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
Table of Contents
Chapter 1. Global Patient Blood Management Market Report Scope & Methodology
- 1.1. Research Objective
- 1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
- 1.3. Research Attributes
- 1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
- 1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study (2023, 2024)
Chapter 2. Executive Summary
- 2.1. CEO/CXO Standpoint
- 2.2. Strategic Insights
- 2.3. ESG Analysis
- 2.4. Key Findings
Chapter 3. Global Patient Blood Management Market Forces Analysis
- 3.1. Market Forces Shaping The Global Patient Blood Management Market (2024-2035)
- 3.2. Drivers
- 3.2.1. Rising volume of surgical procedures and perioperative blood management demands
- 3.2.2. Increasing prevalence of anemia and chronic diseases driving transfusion needs
- 3.3. Restraints
- 3.3.1. High capital expenditure and maintenance costs for advanced PBM instruments
- 3.3.2. Stringent regulatory compliance and complex reimbursement environment
- 3.4. Opportunities
- 3.4.1. Expansion of PBM programs in Asia Pacific and emerging markets
- 3.4.2. Integration of digital solutions, predictive analytics and AI for blood inventory optimization
Chapter 4. Global Patient Blood Management Industry Analysis
- 4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Forecast Model (2024-2035)
- 4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top Investment Opportunities
- 4.5. Top Winning Strategies (2025)
- 4.6. Market Share Analysis (2024-2025)
- 4.7. Global Pricing Analysis And Trends 2025
- 4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Patient Blood Management Market Size & Forecasts by Product 2025-2035
- 5.1. Market Overview
- 5.2. Global Patient Blood Management Market Performance - Potential Analysis (2025)
- 5.3. Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device)
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
- 5.4. Accessories (Syringes, Vials)
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
- 5.5. Reagents
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
- 5.6. Software
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Patient Blood Management Market Size & Forecasts by Component 2025-2035
- 6.1. Market Overview
- 6.2. Global Patient Blood Management Market Performance - Potential Analysis (2025)
- 6.3. Red Blood Cells (RBCs)
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
- 6.4. Platelets
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
- 6.5. Plasma & Cryoprecipitate
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Patient Blood Management Market Size & Forecasts by End User 2025-2035
- 7.1. Market Overview
- 7.2. Global Patient Blood Management Market Performance - Potential Analysis (2025)
- 7.3. Blood Bank
- 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.3.2. Market size analysis, by region, 2025-2035
- 7.4. Hospital
- 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 7.4.2. Market size analysis, by region, 2025-2035
Chapter 8. Global Patient Blood Management Market Size & Forecasts by Region 2025-2035
- 8.1. Patient Blood Management Market, Regional Market Snapshot
- 8.2. Top Leading & Emerging Countries
- 8.3. North America Patient Blood Management Market
- 8.3.1. U.S. Patient Blood Management Market
- 8.3.1.1. Product breakdown size & forecasts, 2025-2035
- 8.3.1.2. End user breakdown size & forecasts, 2025-2035
- 8.3.2. Canada Patient Blood Management Market
- 8.3.2.1. Product breakdown size & forecasts, 2025-2035
- 8.3.2.2. End user breakdown size & forecasts, 2025-2035
- 8.3.1. U.S. Patient Blood Management Market
- 8.4. Europe Patient Blood Management Market
- 8.4.1. UK Patient Blood Management Market
- 8.4.1.1. Product breakdown size & forecasts, 2025-2035
- 8.4.1.2. End user breakdown size & forecasts, 2025-2035
- 8.4.2. Germany Patient Blood Management Market
- 8.4.2.1. Product breakdown size & forecasts, 2025-2035
- 8.4.2.2. End user breakdown size & forecasts, 2025-2035
- 8.4.3. France Patient Blood Management Market
- 8.4.3.1. Product breakdown size & forecasts, 2025-2035
- 8.4.3.2. End user breakdown size & forecasts, 2025-2035
- 8.4.4. Spain Patient Blood Management Market
- 8.4.4.1. Product breakdown size & forecasts, 2025-2035
- 8.4.4.2. End user breakdown size & forecasts, 2025-2035
- 8.4.5. Italy Patient Blood Management Market
- 8.4.5.1. Product breakdown size & forecasts, 2025-2035
- 8.4.5.2. End user breakdown size & forecasts, 2025-2035
- 8.4.6. Rest of Europe Patient Blood Management Market
- 8.4.6.1. Product breakdown size & forecasts, 2025-2035
- 8.4.6.2. End user breakdown size & forecasts, 2025-2035
- 8.4.1. UK Patient Blood Management Market
- 8.5. Asia Pacific Patient Blood Management Market
- 8.5.1. China Patient Blood Management Market
- 8.5.1.1. Product breakdown size & forecasts, 2025-2035
- 8.5.1.2. End user breakdown size & forecasts, 2025-2035
- 8.5.2. India Patient Blood Management Market
- 8.5.2.1. Product breakdown size & forecasts, 2025-2035
- 8.5.2.2. End user breakdown size & forecasts, 2025-2035
- 8.5.3. Japan Patient Blood Management Market
- 8.5.3.1. Product breakdown size & forecasts, 2025-2035
- 8.5.3.2. End user breakdown size & forecasts, 2025-2035
- 8.5.4. Australia Patient Blood Management Market
- 8.5.4.1. Product breakdown size & forecasts, 2025-2035
- 8.5.4.2. End user breakdown size & forecasts, 2025-2035
- 8.5.5. South Korea Patient Blood Management Market
- 8.5.5.1. Product breakdown size & forecasts, 2025-2035
- 8.5.5.2. End user breakdown size & forecasts, 2025-2035
- 8.5.6. Rest of APAC Patient Blood Management Market
- 8.5.6.1. Product breakdown size & forecasts, 2025-2035
- 8.5.6.2. End user breakdown size & forecasts, 2025-2035
- 8.5.1. China Patient Blood Management Market
- 8.6. Latin America Patient Blood Management Market
- 8.6.1. Brazil Patient Blood Management Market
- 8.6.1.1. Product breakdown size & forecasts, 2025-2035
- 8.6.1.2. End user breakdown size & forecasts, 2025-2035
- 8.6.2. Mexico Patient Blood Management Market
- 8.6.2.1. Product breakdown size & forecasts, 2025-2035
- 8.6.2.2. End user breakdown size & forecasts, 2025-2035
- 8.6.1. Brazil Patient Blood Management Market
- 8.7. Middle East and Africa Patient Blood Management Market
- 8.7.1. UAE Patient Blood Management Market
- 8.7.1.1. Product breakdown size & forecasts, 2025-2035
- 8.7.1.2. End user breakdown size & forecasts, 2025-2035
- 8.7.2. Saudi Arabia (KSA) Patient Blood Management Market
- 8.7.2.1. Product breakdown size & forecasts, 2025-2035
- 8.7.2.2. End user breakdown size & forecasts, 2025-2035
- 8.7.3. South Africa Patient Blood Management Market
- 8.7.3.1. Product breakdown size & forecasts, 2025-2035
- 8.7.3.2. End user breakdown size & forecasts, 2025-2035
- 8.7.1. UAE Patient Blood Management Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Fresenius Kabi AG
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Financial Performance (Subject to Data Availability)
- 9.2.5. Product/Services Port
- 9.2.6. Recent Development
- 9.2.7. Market Strategies
- 9.2.8. SWOT Analysis
- 9.3. Terumo Corporation
- 9.4. Haemonetics Corporation
- 9.5. Grifols, S.A.
- 9.6. Macopharma SA
- 9.7. Bio-Rad Laboratories, Inc.
- 9.8. Cerus Corporation
- 9.9. Miltenyi Biotec
- 9.10. Baxter International Inc.
- 9.11. Becton, Dickinson and Company
- 9.12. Danaher Corporation
- 9.13. Siemens Healthineers
- 9.14. Roche Diagnostics
- 9.15. GE Healthcare
- 9.16. Luminex Corporation
